NATCO PHARMA LTD. - 524816 - 40Th Annual General Meeting Of The Company
40th Annual General Meeting of the Company to be held on 29th September, 2023 at 10.30 IST04-09-2023
04-09-2023
NATCO PHARMA LTD. - 524816 - Reg. 34 (1) Annual Report.
Annual Report for the financial year ended 31st March, 202304-09-2023
Natco Pharma shares trade flat on $2 mn investment in US pesticides company
Natco Pharma's objective of the acquisition is investment for bio control of pest.31-08-2023
NATCO PHARMA LTD. - 524816 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201530-08-2023
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificate/Letter of confirmation26-08-2023
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate25-08-2023
Natco Pharma expects to clock Rs 1000-1200 crore profitthis fiscal
Natco Pharma's consolidated net profitincreased 31 per cent to Rs. 420 crore in the first quarter ended June 30, 2023against Rs. 320 crore in the corresponding quarter of the previous financial year21-08-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call transcript for the quarter ended June 30, 202314-08-2023
